Trial Profile

Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer; the HGCSG1401 Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Mar 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Regorafenib (Primary)
Indications Colorectal cancer
Focus Therapeutic Use

Most Recent Events

17 Mar 2017 According to University Hospital Medical Information Network - Japan (UMIN000020861) record, the date for data entry closure is 1 Jun 2016, and the date when trial data was considered complete is 1 Sep 2016.
21 Jan 2017 Results of updated analysis, presented at the 2017 Gastrointestinal Cancers Symposium
02 Oct 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com